Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 69101-69150 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05151588
Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma
PHASE2
Not yet recruiting
30 participants
Started: Sep 1, 2023 · Completed: Aug 31, 2027
1 condition
1 sponsor
0 locations
NCT05970484
Supporting Women in the UK Armed Forces Who Consume Alcohol at an Increased Risk: Refining the DrinksRation Platform
NA
Recruiting
148 participants
Started: Sep 1, 2023 · Completed: Aug 31, 2024
3 conditions
5 sponsors
1 location
NCT06457906
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
PHASE3
Recruiting
340 participants
Started: Sep 1, 2023 · Completed: Feb 28, 2028
6 conditions
1 sponsor
1 location
NCT05166629
Eatable Alphabet as a Nutrition Education Tool
NA
Enrolling by invitation
160 participants
Started: Sep 1, 2023 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05949229
The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery.
PHASE1/PHASE2
Not yet recruiting
42 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06003309
Frequency and E-field Enhancement of ITBS for Depression (FREED)
NA
Recruiting
75 participants
Started: Aug 31, 2023 · Completed: Apr 1, 2025
1 condition
2 sponsors
2 locations
NCT06009029
SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)
PHASE2
Not yet recruiting
96 participants
Started: Aug 31, 2023 · Completed: Jul 31, 2027
1 condition
1 sponsor
0 locations
NCT05883748
Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants with EPP
PHASE2/PHASE3
Enrolling by invitation
200 participants
Started: Aug 31, 2023 · Completed: Jun 30, 2028
1 condition
1 sponsor
11 locations
NCT05708508
Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
PHASE3
Not yet recruiting
144 participants
Started: Aug 31, 2023 · Completed: Jun 1, 2027
1 condition
1 sponsor
0 locations
NCT05773352
Perform® Humeral System - Fracture Study (PFX)
N/A
Active, not recruiting
125 participants
Started: Aug 31, 2023 · Completed: Sep 1, 2033
4 conditions
1 sponsor
9 locations
NCT06059001
Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered Iv in Patients with PDAC
PHASE1
Recruiting
30 participants
Started: Aug 31, 2023 · Completed: Mar 31, 2026
1 condition
1 sponsor
6 locations
NCT06009588
Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
NA
Recruiting
100 participants
Started: Aug 31, 2023 · Completed: Aug 30, 2026
2 conditions
1 sponsor
1 location
NCT05701215
Venetoclax After TKI to Target Persisting Stem Cells in CML
PHASE2
Active, not recruiting
10 participants
Started: Aug 31, 2023 · Completed: Jan 31, 2026
1 condition
3 sponsors
2 locations
NCT05994365
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
N/A
Recruiting
380 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
3 locations
NCT06245759
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
N/A
Recruiting
120,000 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2024
2 conditions
1 sponsor
1 location
NCT06051409
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL.
PHASE3
Recruiting
350 participants
Started: Aug 31, 2023 · Completed: Oct 31, 2028
1 condition
2 sponsors
14 locations
NCT06021470
The StrokeCog Study: Cognitive Rehabilitation Intervention in Stroke
NA
Not yet recruiting
64 participants
Started: Aug 31, 2023 · Completed: Oct 31, 2025
3 conditions
1 sponsor
0 locations
NCT05924269
Role of Neuronal Guidance Proteins as Diagnostic Markers for Acute Kidney Injury (AKI)
N/A
Not yet recruiting
600 participants
Started: Aug 31, 2023 · Completed: Jul 31, 2026
1 condition
1 sponsor
0 locations
NCT05992974
To Identify Urinary Biomarkers Associated With Gestational Diabetes Mellitus [GDM]
N/A
Recruiting
1,000 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
2 locations
NCT06016647
Multi-axis Assessment of Injured Workers
N/A
Recruiting
350 participants
Started: Aug 31, 2023 · Completed: Aug 30, 2025
7 conditions
2 sponsors
1 location
NCT06046066
A Phase 1 Study of NM6603 in Advanced Solid Tumors
PHASE1
Recruiting
36 participants
Started: Aug 31, 2023 · Completed: Feb 28, 2026
1 condition
1 sponsor
4 locations
NCT05788081
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
PHASE2
Active, not recruiting
40 participants
Started: Aug 31, 2023 · Completed: Jun 1, 2027
3 conditions
7 sponsors
5 locations
NCT05684692
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
PHASE2
Recruiting
40 participants
Started: Aug 31, 2023 · Completed: Nov 30, 2027
3 conditions
3 sponsors
1 location
NCT06534489
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
N/A
Recruiting
50 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2029
2 conditions
4 sponsors
1 location
NCT06011980
Life-2023-02 Esophagogastric Variceal Bleeding
NA
Recruiting
33 participants
Started: Aug 31, 2023 · Completed: Aug 10, 2026
1 condition
1 sponsor
1 location
NCT05750329
Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)
NA
Not yet recruiting
30 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2026
3 conditions
3 sponsors
0 locations
NCT05908695
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
PHASE4
Recruiting
1,312 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2029
1 condition
1 sponsor
50 locations
NCT06036810
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
NA
Recruiting
70 participants
Started: Aug 31, 2023 · Completed: Oct 31, 2027
1 condition
2 sponsors
1 location
NCT06020833
A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS
PHASE1/PHASE2
Not yet recruiting
25 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
0 locations
NCT06183554
CXCR4 Targeted PET Imaging in the Diagnosis and Identification of Primary Aldosteronism
N/A
Recruiting
60 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05914389
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
PHASE2
Recruiting
100 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2030
1 condition
1 sponsor
1 location
NCT05983172
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
N/A
Enrolling by invitation
1,500 participants
Started: Aug 31, 2023 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT05974033
IntraCranial Angiography-derived Fraction Flow-guided Percutaneous Transluminal Angioplasty and Stenting Versus Medical Therapy (ICAS-MT)
NA
Not yet recruiting
536 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
0 locations
NCT05951023
Endotype-Targeted Therapy to Rescue OSA Patients Struggling with CPAP Adherence (TOP-CPAP)
PHASE2
Recruiting
50 participants
Started: Aug 31, 2023 · Completed: Apr 30, 2025
1 condition
2 sponsors
1 location
NCT05361941
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities
NA
Recruiting
204 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
12 locations
NCT06042764
SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients
PHASE2
Recruiting
150 participants
Started: Aug 31, 2023 · Completed: Aug 30, 2024
1 condition
1 sponsor
1 location
NCT05852743
Comparative Study Between Shear and Strain Elastography in Monitoring the Response to NAC in Breast Cancer Patients
N/A
Not yet recruiting
65 participants
Started: Aug 31, 2023 · Completed: Apr 30, 2026
1 condition
1 sponsor
0 locations
NCT05870150
Challenge Non-Typhoidal Salmonella (CHANTS) Study
NA
Active, not recruiting
80 participants
Started: Aug 31, 2023 · Completed: Feb 28, 2026
8 conditions
5 sponsors
1 location
NCT06135766
Evaluating the Effectiveness of a School-based Intervention to Improve the Wellbeing of Children Aged 10 to 13 Years.
NA
Recruiting
300 participants
Started: Aug 31, 2023 · Completed: Jun 30, 2024
2 conditions
1 sponsor
1 location
NCT05987826
Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC
PHASE2
Not yet recruiting
40 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition
5 sponsors
0 locations
NCT06320210
Chicago Asthma School-Directed Child-Centered Assessment and Dissemination of Evidence
NA
Recruiting
400 participants
Started: Aug 31, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05883254
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia
N/A
Not yet recruiting
80 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
0 locations
NCT06172374
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
N/A
Active, not recruiting
150 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT06015191
Remote Cardiac Rehab for Adolescents With Congenital Heart Disease
NA
Recruiting
74 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2027
1 condition
5 sponsors
1 location
NCT05963087
Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer
NA
Not yet recruiting
22 participants
Started: Aug 31, 2023 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05971589
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
EARLY_PHASE1
Not yet recruiting
5 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
0 locations
NCT06138340
The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma
N/A
Recruiting
120 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06016842
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
PHASE3
Recruiting
276 participants
Started: Aug 31, 2023 · Completed: May 31, 2029
1 condition
1 sponsor
158 locations
NCT06028308
The Effect of Adding Auditory Information on Head Movements in People With Traumatic Neck Pain
NA
Not yet recruiting
44 participants
Started: Aug 31, 2023 · Completed: Sep 30, 2026
2 conditions
1 sponsor
2 locations
NCT05945758
Esthetic and Clinical Assessment of Injectable Resin Composite Technique
NA
Not yet recruiting
20 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
0 locations
Previous
1
More pages
1380
1381
1382
1383
1384
1385
1386
More pages
2369
Next